Formycon AG (FYB.DE) has a MoatMap StockRank of 19/100 based on Quality (37/100), Value (43/100), and Momentum (30/100) factor scores. The current signal is STRONG SELL. Formycon AG is a biotech company with inherent R&D risks and lacks the predictable cash flows and clear moat required for a quality compounder, with no specific macro tailwind.